GILD
Price:
$123.76
Market Cap:
$153.66B
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vo...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
Dividends are a key part of long-term returns for investors, and Gilead Sciences, Inc. (GILD) has a track record worth reviewing. Looking at dividend history for GILD gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-06-15
Dividend Yield
2.60%
Annual Dividend
$0.82
P/E Ratio
14.79
Payout Ratio
0.44
Dividend per Share
$3.22
EPS
8.37
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-06-15 | $0.82 | $0.82 | 2026-06-29 | 2026-04-29 |
| 2026-03-13 | $0.82 | $0.82 | 2026-03-30 | 2026-02-04 |
| 2025-12-15 | $0.79 | $0.79 | 2025-12-30 | 2025-10-28 |
| 2025-09-15 | $0.79 | $0.79 | 2025-09-29 | 2025-07-29 |
| 2025-06-13 | $0.79 | $0.79 | 2025-06-27 | 2025-04-22 |
| 2025-03-14 | $0.79 | $0.79 | 2025-03-28 | 2025-02-11 |
| 2024-12-13 | $0.77 | $0.77 | 2024-12-30 | 2024-11-06 |
| 2024-09-13 | $0.77 | $0.77 | 2024-09-27 | 2024-08-08 |
| 2024-06-14 | $0.77 | $0.77 | 2024-06-27 | 2024-04-25 |
| 2024-03-14 | $0.77 | $0.77 | 2024-03-28 | 2024-02-01 |
| 2023-12-14 | $0.75 | $0.75 | 2023-12-28 | 2023-11-07 |
The table below shows Gilead Sciences, Inc. (GILD) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Gilead Sciences, Inc. (GILD) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Pfizer Inc. (PFE) | 0.07% |
| Amgen Inc. (AMGN) | 0.03% |
| Sanofi (SNY) | 0.06% |
| Bristol-Myers Squibb Company (BMY) | 0.05% |
| GSK plc (GSK) | 0.03% |
| Merck & Co., Inc. (MRK) | 0.03% |
| Danaher Corporation (DHR) | 0.01% |
| Novo Nordisk A/S (NVO) | 0.04% |
| Stryker Corporation (SYK) | 0.01% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Gilead Sciences, Inc. (GILD) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is GILD’s dividend yield?
What is the difference between regular and special dividends?
Has GILD increased its dividends over time?
Why might dividend history data be delayed?
How often does GILD pay dividends?
What factors impact GILD's dividend payments?
Can dividends change over time?
What is GILD’s next dividend date?